Literature DB >> 8486670

Interactions between the bone matrix proteins osteopontin and bone sialoprotein and the osteoclast integrin alpha v beta 3 potentiate bone resorption.

F P Ross1, J Chappel, J I Alvarez, D Sander, W T Butler, M C Farach-Carson, K A Mintz, P G Robey, S L Teitelbaum, D A Cheresh.   

Abstract

We have investigated the mechanism by which osteoclasts adhere to and resorb bone. We show that these cells express beta 1 and beta 3 integrins which are involved in attachment to purified bone matrix proteins. Binding to osteopontin and bone sialoprotein is mediated by alpha v beta 3, while a beta 1 integrin is responsible for attachment to fibronectin. Both the rapid attachment by osteoclasts to intact bone particles and their subsequent resorption are blocked by a monoclonal antibody directed to the alpha v beta 3 complex but not by an antibody against beta 1 integrins. Attachment of osteoclasts to bone is also inhibited with soluble osteopontin, Arg-Gly-Asp-containing peptides derived from both osteopontin and bone sialoprotein, or a monospecific polyclonal antibody against osteopontin. We conclude that both osteoclast adherence to bone and subsequent resorption of its matrix are dependent on interactions between the bone matrix proteins osteopontin and/or bone sialoprotein and the integrin alpha v beta 3. Moreover, collagen, which constitutes 90% of its organic matrix, is minimally involved in binding of chicken osteoclasts to bone.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8486670

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  98 in total

Review 1.  The role of alpha(v)beta(3) in prostate cancer progression.

Authors:  Carlton R Cooper; Christopher H Chay; Kenneth J Pienta
Journal:  Neoplasia       Date:  2002 May-Jun       Impact factor: 5.715

Review 2.  Vascular calcification and its relation to bone calcification: possible underlying mechanisms.

Authors:  Nilam Mody; Yin Tintut; Kristen Radcliff; Linda L Demer
Journal:  J Nucl Cardiol       Date:  2003 Mar-Apr       Impact factor: 5.952

3.  Osteoblastic meningiomas: clinico-pathological and immunohistochemical features of an uncommon variant.

Authors:  V Barresi; M Caffo; A Ieni; C Alafaci; G Tuccari
Journal:  J Neurooncol       Date:  2011-04-22       Impact factor: 4.130

4.  The isolation and characterization of glycosylated phosphoproteins from herring fish bones.

Authors:  Hai-Yan Zhou; Erdjan Salih; Melvin J Glimcher
Journal:  J Biol Chem       Date:  2010-09-10       Impact factor: 5.157

5.  Osteochondral interface tissue engineering using macroscopic gradients of bioactive signals.

Authors:  Nathan H Dormer; Milind Singh; Limin Wang; Cory J Berkland; Michael S Detamore
Journal:  Ann Biomed Eng       Date:  2010-04-09       Impact factor: 3.934

6.  Bisphosphonates inhibit the adhesion of breast cancer cells to bone matrices in vitro.

Authors:  G van der Pluijm; H Vloedgraven; E van Beek; L van der Wee-Pals; C Löwik; S Papapoulos
Journal:  J Clin Invest       Date:  1996-08-01       Impact factor: 14.808

Review 7.  Osteoclasts: New Insights.

Authors:  Xu Feng; Steven L Teitelbaum
Journal:  Bone Res       Date:  2013-03-29       Impact factor: 13.567

8.  Tumor-selective response to antibody-mediated targeting of alphavbeta3 integrin in ovarian cancer.

Authors:  Charles N Landen; Tae-Jin Kim; Yvonne G Lin; William M Merritt; Aparna A Kamat; Liz Y Han; Whitney A Spannuth; Alpa M Nick; Nicholas B Jennnings; Michael S Kinch; David Tice; Anil K Sood
Journal:  Neoplasia       Date:  2008-11       Impact factor: 5.715

9.  Response of cementoblast-like cells to mechanical tensile or compressive stress at physiological levels in vitro.

Authors:  Lan Huang; Yao Meng; Aishu Ren; Xianglong Han; Ding Bai; Lina Bao
Journal:  Mol Biol Rep       Date:  2008-10-11       Impact factor: 2.316

Review 10.  The role of osteopontin in kidney diseases.

Authors:  Beata Kaleta
Journal:  Inflamm Res       Date:  2018-11-19       Impact factor: 4.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.